8686 Venugopala et al.
Asian J. Chem.
frequently needed exercise in medicinal chemistry. Generally
amine can be protected by di-tert-butyl dicarbonate (Boc
anhydride)25, benzyl chloroformate (CBZ chloride)26, allyl
chloride27,28, N-(9H-fluoren-2-ylmethoxycarbonyloxy) succi-
nimide27,29,30.According to reported literature, these protecting
groups are very sensitive to acidic, basic or catalytic hydroge-
nation conditions. Hence acetonylacetone could acts as an
amine-protecting agent in multistep organic synthesis due
to the stability of 2,5-dimethyl-1-substituted pyrroles (Scheme-
II).
MHz, CDCl3): δ = 13, 23, 44, 109, 125, 127, 128, 134, 140.
LC-MS: m/z = 200 (M+).
1-(4-Butyl-3-fluoro-phenyl)-2,5-dimethyl-1H-pyrrole
(1e): 1H NMR (400 MHz, CDCl3): δ = 1.0 (t, 3H), 1.33 (m,
2H), 1.62 (m, 2H), 2.0 (s, 6H), 2.5 (t, 2H), 5.7 (s, 2H), 6.9 (d,
2H), 7.1 (s, 1H). 13C NMR (400 MHz, CDCl3): δ = 11, 14, 22,
24, 34, 107, 110, 115, 123, 130, 131, 139, 162. LC-MS: m/z =
245 (M+).
[5-Chloro-2-(2, 5-dimethyl-1H-pyrrol-1-yl) phenyl](3-
fluorophenyl)methanone (1f): 1H NMR (400 MHz, CDCl3):
δ = 1.9 (s, 6H), 5.5 (s, 2H), 6.96-7.08 (m, 1H), 7.08-7.10 (q,
1H), 7.20-7.25 (m, 1H), 7.30-7.31 (m, 2H), 7.58-7.67 (q, 1H),
7.68 (s, 1H). 13C NMR (400 MHz, CDCl3): δ = 13, 110, 117,
119, 121, 125, 129, 130, 131, 133, 139, 140, 161, 187. LC-
MS: m/z = 328 (M+).
TFA (10 mmol)
N
Ar
Ar
NH2
Reflux, 48 h
Methyl [4-(2,5-dimethyl-1H-pyrrol-1-yl)phenyl]acetate
1
(1g): H NMR (400 MHz, CDCl3): δ = 2.04 (s, 6H), 3.5 (s,
Ar = substituted aryl/heteroaryl group
Scheme-II: Deprotection of 2,5-dimethyl-1-substituted pyrrole by
trifluoroacetic acid to substituted aryl/heteroaryl amines
3H), 3.7 (s, 2H), 5.91 (s, 2H), 7.16-7.18 (q, 2H), 7.27-7.38
(m, 2H). 13C NMR (400 MHz, CDCl3): δ = 12, 40, 52, 112,
121, 131, 132, 133, 140, 174. LC-MS: m/z = 244 (M+).
N-[2-(2,5-Dimethyl-1H-pyrrol-1-yl)-4-methoxy-
EXPERIMENTAL
Chemicals, solvents and catalysts were procured from
SigmaAldrich Company and used without further purification.
TLC was performed on Merck 60 F254 silica gel plates. 1H and
13C NMR spectra were recorded on 400 MHz Brucker spec-
trometer using CDCl3 as a solvent. Chemical shifts (δ) were
indicated in parts per million downfield from TMS. Mass spec-
tra were recorded using LC-MS-Agilent 1100 series with MSD
(ion trap) using 0.1 % aqueous trifluoo acetic acid in acetonitrile
system on C18-BDS column.
1
phenyl]benzamide (1h): H NMR (400 MHz, CDCl3): δ =
2.0 (s, 6H), 3.8 (s, 3H), 5.91 (s, 2H), 7.14-7.18 (q, 2H) 7.39-
7.41 (t, 2H), 7.63-7.69 (m, 2H), 7.67 (s, 1H), 7.7 (s, 1H), 8.02-
8.05 (q, 1H). 13C NMR (400 MHz, CDCl3): δ = 12, 57, 108,
112, 113, 122, 123, 128, 129, 132, 133, 134, 135, 159, 166.
LC-MS: m/z = 321 (M+).
1
3-(2, 5-Dimethyl-1H-pyrrol-1-yl)quinoline (1i)35: H
NMR (400 MHz, CDCl3): δ = 2.1 (s, 6H), 5.9 (s, 2H), 7.65-
7.67 (d, 1H ) 7.79-7.82 (q, 1H), 7.88-7.90 (d, 1H), 8.0 (d,
1H), 8.1-8.2 (d, 1H), 8.80-8.81 (d, 1H). 13C NMR (400 MHz,
CDCl3): δ = 13, 108,126, 127, 128, 129, 130, 133, 141, 144.
LC-MS: m/z = 222 (M+).
General procedure for the synthesis of 2,5-dimethyl-
1-substituted pyrrole (1a-m): Aromatic/heteroaromatic
amine (10 mmol), acetonylacetone (10 mmol) and
trifluoroacetic acid (2 mmol) were taken in MDC (5 mL)
under nitrogen atmosphere and stirred for about 1 h (moni-
tored by thin layer chromatography). After completion of the
reaction, it was quenched by 10 % sodium bicarbonate solu-
tion, extracted twice with MDC, dried and concentrated. The
crude product was purified by column chromatography by
eluting with n-hexane-ethyl acetate mixture (10-30 %). All
the synthesized products were characterized by spectral data.
4-(2, 5-Dimethyl-1H-pyrrol-1-yl)-2-fluorophenol (1a):
1H NMR (400 MHz, CDCl3): δ = 2.1 (s, 6H), 5.4 (s, 1H), 5.89
(s, 2H), 6.90-6.91 (m, 1H), 6.94-6.98 (d, 1H), 7.00-7.19 (m,
1H). 13C NMR (400 MHz, CDCl3): δ = 12, 109, 111, 117, 118,
132, 134, 141, 149. LC-MS: m/z = 212 (M+).
4-(2, 5-Dimethyl-1H-pyrrol-1-yl)-2-methyl-1H-indole
(1j): 1H NMR (400 MHz, CDCl3): δ = 2.10 (s, 6H), 2.47 (s,
3H), 5.90 (s, 2H), 6.20-6.21 (q, 1H), 6.93-6.95 (q, 1H), 7.32-
7.35 (m, 2H), 8.03-8.05 (s, 1H). 13C NMR (400 MHz, CDCl3):
δ = 13, 100, 104, 110, 110.1, 119, 121, 129, 131, 135, 136.
LC-MS: m/z = 225 (M+).
1
7- (2,5-Dimethyl-1H-pyrrol-1-yl)-1H-indole (1k): H
NMR (400 MHz, CDCl3): δ = 2.01 (s, 6H), 5.9 (s, 2H), 7.02-
7.05 (q, 1H), 7.39-7.40 (d, 1H), 7.80-7.81 (q, 1H), 8.20-8.21
(d, 1H), 11.0 (br, 1H). 13C NMR (400 MHz, CDCl3): δ = 13,
105, 109, 112.1, 122, 122.4, 129, 134, 137, 140. LC-MS: m/z
= 212 (M+).
5-(2, 5-Dimethyl-1H-pyrrol-1-yl)-1-methyl-3-phenyl-
1H-pyrazole (1m): 1H NMR (400 MHz, CDCl3): δ = 1.99 (s,
6H), 3.5 (s, 3H), 5.9 (s, 2H), 6.59 (s, 1H), 7.2 (q, 1H), 7.41-
7.45 (m, 2H), 7.82-7.86 (m, 2H). 13C NMR (400 MHz, CDCl3):
δ = 13, 25, 105, 108, 127, 128, 130, 132, 133, 149. LC-MS:
m/z = 252 (M+).
2, 5-Dimethyl-1-[4-(trifluoromethyl)phenyl]-1H-
pyrrole (1b)31: 1H NMR (400 MHz, CDCl3): δ = 2.1 (s, 6H),
5.9 (s, 2H), 7.36-7.38 (d, 2H), 7.7-7.8 (d, 2H). 13C NMR (400
MHz, CDCl3): δ = 12, 111, 120, 121, 126, 128, 132, 144. LC-
MS: m/z = 240 (M+).
1-(4-Bromophenyl)-2, 5-dimethyl-1H-pyrrole (1c)32,33
:
1H NMR (400 MHz, CDCl3): δ = 2.01 (s, 6H), 5.91 (s, 2H),
7.09-7.18 (d, 2H), 7.57-7.60 (d, 2H). 13C NMR (400 MHz,
CDCl3): δ = 12, 111, 120, 123, 132, 133, 140. LC-MS: m/z =
251 (M+).
General procedure for the deprotection of 2,5-dimethyl-
1-substituted pyrrole to substituted aryl/heteroaryl amine
(2a-m): 2,5-Dimethyl-1-substituted pyrrole (1 mmol) was
taken in 50 mL round bottom flask, trifluoroacetic acid (10
mmol) was added and refluxed for 48 h. Completion of reaction
was monitored through thin layer chromatography. After
reaction completion, the reaction was quenched by 10 %
sodium bicarbonate solution and extracted twice with MDC,
2,5-Dimethyl-1-[(1R)-1-phenylethyl]-1H-pyrrole
(1d)21,34: 1H NMR (400 MHz, CDCl3): δ = 1.86-1.88 (d, 3H),
2.09 (s, 6H), 5.40-5.49 (m, 1H), 5.80 (s, 2H), 7.04-7.06 (t,
2H), 7.24-7.27 (m, 1H), 7.28-7.39 (m, 1H). 13C NMR (400